Search - tctmd.com

Displaying 421 - 440 of 475

Sort: Relevancy | Date

Presentation TCT 2012

Tools for Everyday Use of AUC

Presenter: Steven Bailey

October 24, 2012

Presentation TCT 2012

The Hippocratic Oath as a Guide Rather than the AUC

Presenter: J. Jeffrey Marshall

October 24, 2012

Presentation TCT 2012

AUC and State PCI Registries: The Michigan State PCI Registry Example

Presenter: Hitinder Gurm

October 24, 2012

Presentation TCT 2012

Updated CRT Guidelines

Presenter: William Abraham

October 23, 2012

Presentation TCT 2012

Synthesis of the New ESC LAA Closure Guidelines

Presenter: Peter Sick

October 23, 2012

Presentation TCT 2012

Practice Trends in the United States: Nonadherence to the Mitral Valve Guidelines

Presenter: James Gammie

October 23, 2012

Presentation TCT 2012

Essentials of Carotid Artery Diseases: Guidelines, Assessment, and Outcomes

Presenter: Jose Wiley

October 23, 2012

Presentation TCT 2012

Essentials of Aortic and Peripheral Arterial (Upper/Lower Extremity) Diseases: Guidelines, Assessment, and Outcomes

Presenter: Jeffrey Olin

October 23, 2012

Presentation TCT 2012

The 2012 ESC Mitral Valve Guidelines: What's New, and How Should They Affect Practice?

Presenter: Francesco Maisano

October 23, 2012

Presentation TCT 2012

TCT-99. The Vancouver Computed Tomography Sizing Guidelines for Transcatheter Aortic Valve Replacement with Balloon Expandable Valves

Presenter: Alex Willson

October 23, 2012

Presentation TCT 2012

Physiologic Lesion Assessment: Key Clinical Results, Guidelines, and Case Presentations (with Integrated Q&A)

Presenter: Michael Lim

October 23, 2012

Presentation TCT 2012

Intravascular Ultrasound, Near Infrared Spectroscopy and OCT: Key Clinical Results, Guidelines, and Case Examples (with Integrated Q&A)

Presenter: Gary Mintz

October 23, 2012

Presentation TCT 2012

Essentials of Renal Artery Disease: Guidelines, Assessment, and Outcomes

Presenter: Jeffrey Olin

October 23, 2012

Presentation TCT 2012

Yes: It's in the Guidelines, and It's Evidence-Based!

Presenter: Samin Sharma

October 22, 2012

Presentation TCT 2012

Yes: It's in the Guidelines and Ensures Patient Consent and Optimal Treatment Decisions!

Presenter: David Taggart

October 22, 2012

Presentation TCT 2012

The Multidisciplinary Team: What Is Really Involved?

Presenter: Michael Mack

October 22, 2012

Presentation TCT 2012

The FDA View(2)

Presenter: Andrew Farb

October 22, 2012

Presentation TCT 2012

Screening and Enrollment(2)

Presenter: George Dangas

October 22, 2012

Presentation TCT 2012

Quality of Life: Should This Be the Key Parameter in Choosing Therapies?

Presenter: John Spertus

October 22, 2012

Presentation TCT 2012

New Pacemakers After TAVR: Frequency, Predictors, Clinical Outcomes, and Guidelines on “When to Treat”

Presenter: Jeffrey Popma

October 22, 2012

Advertisement

Tools for Everyday Use of AUC

The Hippocratic Oath as a Guide Rather than the AUC

AUC and State PCI Registries: The Michigan State PCI Registry Example

Updated CRT Guidelines

Synthesis of the New ESC LAA Closure Guidelines

Practice Trends in the United States: Nonadherence to the Mitral Valve Guidelines

Essentials of Carotid Artery Diseases: Guidelines, Assessment, and Outcomes

Essentials of Aortic and Peripheral Arterial (Upper/Lower Extremity) Diseases: Guidelines, Assessment, and Outcomes

The 2012 ESC Mitral Valve Guidelines: What's New, and How Should They Affect Practice?

TCT-99. The Vancouver Computed Tomography Sizing Guidelines for Transcatheter Aortic Valve Replacement with Balloon Expandable Valves

Physiologic Lesion Assessment: Key Clinical Results, Guidelines, and Case Presentations (with Integrated Q&A)

Intravascular Ultrasound, Near Infrared Spectroscopy and OCT: Key Clinical Results, Guidelines, and Case Examples (with Integrated Q&A)

Essentials of Renal Artery Disease: Guidelines, Assessment, and Outcomes

Yes: It's in the Guidelines, and It's Evidence-Based!

Yes: It's in the Guidelines and Ensures Patient Consent and Optimal Treatment Decisions!

The Multidisciplinary Team: What Is Really Involved?

The FDA View(2)

Screening and Enrollment(2)

Quality of Life: Should This Be the Key Parameter in Choosing Therapies?

New Pacemakers After TAVR: Frequency, Predictors, Clinical Outcomes, and Guidelines on “When to Treat”

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content